XML 69 R55.htm IDEA: XBRL DOCUMENT v3.21.2
Description of Organization and Business Operations (Detail) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 04, 2021
Oct. 02, 2020
Oct. 02, 2020
Mar. 31, 2021
Dec. 31, 2020
Description of Organization and Business Operations (Details) [Line Items]          
Proceeds from issuance of private placement         $ 14,000,000
Offering costs allocated to warrant liability         $ 1,015,795
Aggregate fair market value least percentage         80.00%
Business acquisition percentage         50.00%
Public shares price per share (in Dollars per share)         $ 10.00
Minimum net tangible assets to required business combination         $ 5,000,001
Redemption percentage         15.00%
Interest to pay dissolution expenses     $ 100,000    
Business combination, description         the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.00 per Public Share or (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay our taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and will not apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Agreement, description         Pursuant to the Merger Agreement, the aggregate merger consideration payable to the stockholders of HydraFacial will be paid in a combination of stock and cash equal to $975,000,000, subject to adjustments, (the “Merger Consideration”). The cash consideration will be an amount equal to the Company’s cash and cash equivalents as of the Closing (including proceeds in connection with the Private Placement and the funds in the Company’s Trust Account), minus HydraFacial’s outstanding indebtedness at the closing, minus transaction expenses of HydraFacial and the Company, minus $100,000,000. However, cash consideration, together with certain contractual fee payments, will be subject to a maximum of 60% of the aggregate Merger Consideration. The remainder of the Merger Consideration will be paid in a number of shares of newly issued Class A common stock of the Company (“Company Common Stock”) valued at $10.00 per share.
Proceeds from issuance of stock         $ 25,000
Cash       $ 2,753,154 3,265,075
Marketable securities held in Trust Account       460,184,400 460,098,212
Total Current Liabilities       $ 813,471 $ 765,497
Subsequent Event [Member] | PIPE Subscription Agreement [Member] | PIPE Investor [Member] | PIPE Investment [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Proceeds from issuance of stock $ 350,000,000        
Hydra Facial [Member] | Subsequent Event [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Proceeds from issuance of private placement $ 350,000,000        
Business acquisition percentage 100.00%        
Business acquisition, description (a) the merger of Merger Sub I with and into HydraFacial, with HydraFacial continuing as the surviving corporation (the “First Merger”), and (b) immediately following the First Merger and as part of the same overall transaction as the First Merger, the merger of HydraFacial with and into Merger Sub II, with Merger Sub II continuing as the surviving entity (the “Second Merger” and, together with the First Merger, the “Mergers” and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”).     (a) the merger of Merger Sub I with and into HydraFacial, with HydraFacial continuing as the surviving corporation (the “First Merger”), and (b) immediately following the First Merger and as part of the same overall transaction as the First Merger, the merger of HydraFacial with and into Merger Sub II, with Merger Sub II continuing as the surviving entity (the “Second Merger” and, together with the First Merger, the “Mergers” and, together with the other transactions contemplated by the Merger Agreement, the “Business Combination”).  
Agreement, description Pursuant to the terms of the Merger Agreement and customary adjustments set forth therein, the aggregate merger consideration paid to the HydraFacial Stockholders in connection with the Business Combination was approximately $975,000,000 less HydraFacial’s net indebtedness as of the Closing Date, and subject to further adjustments for transaction expenses, and net working capital relative to a target. The merger consideration included both cash consideration and consideration in the form of newly issued Class A Stock.        
Aggregate merger consideration $ 975,000,000        
Aggregate cash consideration 368,000,000        
Cash available in trust account 433,000,000        
Amount used to repay of indebtedness 224,000,000        
Transaction expenses of Hydrafacial 94,000,000        
Other expenses amount $ 100,000,000        
Hydra Facial [Member] | Subsequent Event [Member] | First Merger [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Business acquisition percentage 100.00%        
Hydra Facial [Member] | Subsequent Event [Member] | Second Merger [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Business acquisition percentage 100.00%        
HydraFacial And Subsidiaries [Member] | Subsequent Event [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Business acquisition percentage 100.00%        
Sponsor [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Public shares redemption percentage         100.00%
Initial Public Offering [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Consummated sale of units (in Shares)     46,000,000    
Transaction costs       $ 25,777,859 $ 25,777,859
Underwriting fees       9,200,000 9,200,000
Deferred underwriting fee       16,100,000 16,100,000
Other offering costs       $ 477,859 477,859
Stock Issued, Issuance Costs         24,762,064
Offering costs allocated to warrant liability         $ 1,015,795
Initial public offering price per unit (in Dollars per share)         $ 10.00
Price per share   $ 10.00 $ 10.00    
Over-Allotment Option [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Consummated sale of units (in Shares)     6,000,000    
Stock price per unit (in Dollars per share)   10.00 $ 10.00    
Private Placement [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Proceeds from issuance of initial public offering     $ 460,000,000    
Private Placement Warrants [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Consummated sale of units (in Shares)     9,333,333    
Stock price per unit (in Dollars per share)   $ 1.50 $ 1.50 $ 1.50 $ 1.50
Proceeds from issuance of private placement   $ 4,800,000   $ 14,000,000 $ 14,000,000
Class A Common Stock          
Description of Organization and Business Operations (Details) [Line Items]          
Common stock par value (in Dollars per share)       $ 0.0001 $ 0.0001
Exercise of right to redeem shares for cash         46,000,000
Price per share   $ 11.50 $ 11.50 $ 11.50 $ 11.50
Common stock, shares outstanding       0 0
Class A Common Stock | After Merger and PIPE Investment [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Common stock, shares outstanding       125,329,053  
Class A Common Stock | Subsequent Event [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Common stock conversion basis one-for-one        
Exercise of right to redeem shares for cash 2,672,690        
Redemption price per share $ 10.00        
Payments for repurchase of stock $ 26,737,737        
Common stock, shares outstanding 125,329,053        
Class A Common Stock | Subsequent Event [Member] | PIPE Subscription Agreement [Member] | PIPE Investor [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Stock price per unit (in Dollars per share) $ 10.00        
Class A Common Stock | Hydra Facial [Member] | Subsequent Event [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Stock consideration 35,501,743        
Class A Common Stock | HydraFacial And Subsidiaries [Member] | Subsequent Event [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Common stock par value (in Dollars per share) $ 0.0001        
Class A Common Stock | Initial Public Offering [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Consummated sale of units (in Shares)     46,000,000    
Class A Common Stock | Private Placement [Member] | Hydra Facial [Member] | Subsequent Event [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Stock issued during period shares new shares 35,000,000        
Earn Out Shares of Class A Common Stock [Member] | Hydra Facial [Member] | Subsequent Event [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Increase in foregoing consideration payment $ 75,000,000        
PIPE Shares [Member] | Subsequent Event [Member] | PIPE Subscription Agreement [Member] | PIPE Investor [Member]          
Description of Organization and Business Operations (Details) [Line Items]          
Stock issued during period shares new shares 35,000,000        
Price per share $ 10.00